Smallpox News and Research

RSS
Smallpox is a highly contagious disease caused by the variola virus, a member of the Orthopox virus family. It is one of the most devastating diseases known to humanity, with a mortality rate as high as 30%. In 1967, the World Health Organization embarked upon an intensified vaccination campaign to eliminate smallpox, which culminated in the successful eradication of the disease globally by 1980.

By the mid-1980s, there were only two known repositories of variola virus: the Institute of Virus Preparations in Russia, and the US CDC. The events in the US in September and October 2001 highlighted the risk that the variola virus might be used as an agent of bioterrorism. Governments around the world are taking precautionary measures to be ready to deal with a potential smallpox outbreak.
Federal cuts ripple through a bioscience hub in rural Montana

Federal cuts ripple through a bioscience hub in rural Montana

US withdrawal from global health bodies threatens millions with hunger and disease

US withdrawal from global health bodies threatens millions with hunger and disease

Measles could return to endemic status if US vaccination rates fall further

Measles could return to endemic status if US vaccination rates fall further

New vaccine targets sugar shield to protect against multiple coronaviruses

New vaccine targets sugar shield to protect against multiple coronaviruses

Mpox virus poses rising global epidemic and pandemic threat

Mpox virus poses rising global epidemic and pandemic threat

Research highlights rising risk of human-to-human mpox transmission

Research highlights rising risk of human-to-human mpox transmission

Artificial intelligence tool predicts virus outbreak hotspots

Artificial intelligence tool predicts virus outbreak hotspots

The impact of ending U.S.-funded global vaccine programs

The impact of ending U.S.-funded global vaccine programs

Scientists develop universal vaccine targeting multiple coronaviruses

Scientists develop universal vaccine targeting multiple coronaviruses

Tecovirimat monotherapy found ineffective for treating clade II mpox in NIH-sponsored trial

Tecovirimat monotherapy found ineffective for treating clade II mpox in NIH-sponsored trial

Engineering safe and effective vaccinia virus vectors for next-generation vaccines

Engineering safe and effective vaccinia virus vectors for next-generation vaccines

Study explains why tecovirimat fails against some mpox strains

Study explains why tecovirimat fails against some mpox strains

The growing list of human viruses: Are we prepared for the next outbreak?

The growing list of human viruses: Are we prepared for the next outbreak?

WHO regrets United States’ decision to withdraw from the organization

WHO regrets United States’ decision to withdraw from the organization

Syphilis family traced to Pre-Columbian Americas

Syphilis family traced to Pre-Columbian Americas

Interim analysis of STOMP study finds no efficacy for tecovirimat in mild to moderate Mpox cases

Interim analysis of STOMP study finds no efficacy for tecovirimat in mild to moderate Mpox cases

How measles, whooping cough, and worse could roar back on RFK Jr.’s watch

How measles, whooping cough, and worse could roar back on RFK Jr.’s watch

Scientists fear what’s next for public health if RFK Jr. is allowed to ‘go wild’

Scientists fear what’s next for public health if RFK Jr. is allowed to ‘go wild’

As nuns disappear, many Catholic hospitals look more like megacorporations

As nuns disappear, many Catholic hospitals look more like megacorporations

Vaccination of young children could dramatically reduce mpox deaths in DRC

Vaccination of young children could dramatically reduce mpox deaths in DRC

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.